|
1
|
Osimo EF, Baxter LJ, Lewis G, Jones PB and
Khandaker GM: Prevalence of low-grade inflammation in depression: A
systematic review and meta-analysis of CRP levels. Psychol Med.
49:1958–1970. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Köhler O, Krogh J, Mors O and Benros ME:
Inflammation in depression and the potential for anti-inflammatory
treatment. Curr Neuropharmacol. 14:732–742. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dinan TG: Inflammatory markers in
depression. Curr Opin Psychiatry. 22:32–36. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Howren MB, Lamkin DM and Suls J:
Associations of depression with C-reactive protein, IL-1, and IL-6:
A meta-analysis. Psychosom Med. 71:171–186. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Janssen DG, Caniato RN, Verster JC and
Baune BT: A psychoneuroimmunological review on cytokines involved
in antidepressant treatment response. Hum Psychopharmacol.
25:201–215. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Dickens C, McGowan L, Clark-Carter D and
Creed F: Depression in rheumatoid arthritis: A systematic review of
the literature with meta-analysis. Psychosom Med. 64:52–60.
2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gobin V, Van Steendam K, Fevery S,
Tilleman K, Billiau AD, Denys D and Deforce DL: Fluoxetine reduces
murine graft-versus-host disease by induction of T cell
immunosuppression. J Neuroimmune Pharmacol. 8:934–943.
2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kiraly DD, Horn SR, Van Dam NT, Costi S,
Schwartz J, Kim-Schulze S, Patel M, Hodes GE, Russo SJ, Merad M, et
al: Altered peripheral immune profiles in treatment-resistant
depression: Response to ketamine and prediction of treatment
outcome. Transl Psychiatry. 7(e1065)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Al Ustwani O, Gupta N, Bakhribah H,
Griffiths E, Wang E and Wetzler M: Clinical updates in adult acute
lymphoblastic leukemia. Crit Rev Oncol Hematol. 99:189–199.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Matsukuma KE, Wei D, Sun K, Ramsamooj R
and Chen M: Diagnosis and differential diagnosis of hepatic graft
versus host disease (GVHD). J Gastrointest Oncol. 7:S21–S31.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jacobs JM, Fishman S, Sommer R, Sereno I,
Fenech A, Jankowski AL, et al: Coping and modifiable psychosocial
factors are associated with mood and quality of life in patients
with chronic graft-versus-host disease. Biol Blood Marrow
Transplant. 25:2234–2242. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ferrara JL, Levine JE, Reddy P and Holler
E: Graft-versus-host disease. Lancet. 373:1550–1561.
2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sette A, Alexander J and Grey HM:
Interaction of antigenic peptides with MHC and TCR molecules. Clin
Immunol Immunopathol. 76:168–171. 1995.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang Y and Wilson JM: CD40
Ligand-dependent T Cell activation: Requirement of B7-CD28
signaling through CD40. Science. 273:1862–1864. 1996.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jadus MR and Wepsic HT: The role of
cytokines in graft-versus-host reactions and disease. Bone Marrow
Transplant. 10:1–14. 1992.PubMed/NCBI
|
|
16
|
Dean RM, Fry T, Mackall C, Steinberg SM,
Hakim F, Fowler D, Odom J, Foley J, Gress R and Bishop MR:
Association of serum interleukin-7 levels with the development of
acute graft-versus-host disease. J Clin Oncol. 26:5735–5741.
2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Korngold R and Sprent J: T cell subsets
and graft-versus-host disease. Transplantation. 44:335–339.
1987.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Enache D, Pariante CM and Mondelli V:
Markers of central inflammation in major depressive disorder: A
systematic review and meta-analysis of studies examining
cerebrospinal fluid, positron emission tomography and post-mortem
brain tissue. Brain Behav Immun. 81:24–40. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kappelmann N, Lewis G, Dantzer R, Jones PB
and Khandaker GM: Antidepressant activity of anti-cytokine
treatment: A systematic review and meta-analysis of clinical trials
of chronic inflammatory conditions. Mol Psychiatry. 23:335–343.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Strong Rodrigues K, Oliveira-Ribeiro C, de
Abreu Fiuza Gomes S and Knobler R: Cutaneous graft-versus-host
disease: Diagnosis and treatment. Am J Clin Dermatol. 19:33–50.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Syrjala KL, Langer SL, Abrams JR, Storer
B, Sanders JE, Flowers ME and Martin PJ: Recovery and long-term
function after hematopoietic cell transplantation for leukemia or
lymphoma. JAMA. 291:2335–2343. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Felger JC and Lotrich FE: Inflammatory
cytokines in depression: Neurobiological mechanisms and therapeutic
implications. Neuroscience. 246:199–229. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gimeno D, Kivimäki M, Brunner EJ,
Elovainio M, De Vogli R, Steptoe A, Kumari M, Lowe GD, Rumley A,
Marmot MG, et al: Associations of C-reactive protein and
interleukin-6 with cognitive symptoms of depression: 12-year
follow-up of the Whitehall II study. Psychol Med. 39:413–423.
2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Costanzo ES, Juckett MB and Coe CL:
Biobehavioral influences on recovery following hematopoietic stem
cell transplantation. Brain Behav Immun. 30:68–74. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Guyon A, Massa F, Rovère C and Nahon J-L:
How cytokines can influence the brain: A role for chemokines? J
Neuroimmunol. 198:46–55. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
D'Mello C, Le T and Swain MG: Cerebral
microglia recruit monocytes into the brain in response to tumor
necrosis factoralpha signaling during peripheral organ
inflammation. J Neurosci. 29:2089–2102. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Calabrese F, Rossetti AC, Racagni G, Gass
P, Riva MA and Molteni R: Brain-derived neurotrophic factor: A
bridge between inflammation and neuroplasticity. Front Cell
Neurosci. 8(430)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhu C-B, Lindler KM, Owens AW, Daws LC,
Blakely RD and Hewlett WA: Interleukin-1 receptor activation by
systemic lipopolysaccharide induces behavioral despair linked to
MAPK regulation of CNS serotonin transporters.
Neuropsychopharmacology. 35:2510–2520. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Neurauter G, Schröcksnadel K, Scholl-Bürgi
S, Sperner-Unterweger B, Schubert C, Ledochowski M and Fuchs D:
Chronic immune stimulation correlates with reduced phenylalanine
turnover. Curr Drug Metab. 9:622–627. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Maes M, Leonard BE, Myint AM, Kubera M and
Verkerk R: The new ‘5-HT’ hypothesis of depression: Cell-mediated
immune activation induces indoleamine 2,3-dioxygenase, which leads
to lower plasma tryptophan and an increased synthesis of
detrimental tryptophan catabolites (TRYCATs), both of which
contribute to the onset of depression. Prog Neuropsychopharmacol
Biol Psychiatry. 35:702–721. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Turnbull AV and Rivier C: Regulation of
the HPA axis by cytokines. Brain Behav Immun. 9:253–275.
1995.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dinan TG and Scott LV: Anatomy of
melancholia: Focus on hypothalamic-pituitary-adrenal axis
overactivity and the role of vasopressin. J Anat. 207:259–264.
2005.PubMed/NCBI View Article : Google Scholar
|
